Termination of paroxysmal supraventricular tachycardia by intranasal swab insertion.

Termination of paroxysmal supraventricular tachycardia by intranasal swab insertion.

Publication date: Oct 01, 2023

Paroxysmal supraventricular tachycardia (SVT) is a common emergency department presentation. Vagal maneuvers are commonly tried to terminate SVT but are often unsuccessful in terminating the dysrhythmia. The use of adenosine, while often successful, is associated with a number of side effects and is often disliked by patients with recurrent episodes of SVT. We report on a 44-year-old woman with a past medical history of SVT who presented to the emergency department (ED) due to a recurrence of her SVT. The patient had no intravenous access and preferred not to receive adenosine. The patient received intranasal stimulation with a nasopharyngeal swab used for COVID-19 testing for 5-10 s. After less than 10 s, the patient converted to a sinus rhythm. She was successfully discharged from the ED after 1 h of observation and no recurrence of her SVT.

Concepts Keywords
10s Nasopharyngeal swab
Covid Suprventricular tachycardia
Dysrhythmia Vagal stimulation
Old

Semantics

Type Source Name
disease MESH paroxysmal supraventricular tachycardia
disease MESH emergency
drug DRUGBANK Adenosine
disease VO report
disease IDO history
disease MESH COVID-19
disease MESH tachycardia

Original Article

(Visited 1 times, 1 visits today)